Clorox (CLX) financial statements
Clorox reported revenue of $7.1B in fiscal 2025, up 2.4% a year over 9 years.
Net income was $810M.
Free cash flow was $761M, and the company returned $602M in dividends and $332M in net buybacks.
The diluted share count fell 6% over the period (buybacks).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Clorox's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B | $6.0B | $6.1B | $6.2B | $6.7B | $7.3B | $7.1B | $7.4B | $7.1B | $7.1B |
| Cost of revenue | $3.2B | $3.3B | $3.4B | $3.5B | $3.7B | $4.1B | $4.6B | $4.5B | $4.0B | $3.9B |
| Gross profit | $2.6B | $2.7B | $2.7B | $2.7B | $3.1B | $3.2B | $2.5B | $2.9B | $3.0B | $3.2B |
| Research and development | $141M | $135M | $132M | $136M | $145M | $149M | $132M | $138M | $126M | $121M |
| Selling, general and admin | $806M | $810M | $837M | $856M | $969M | $1.0B | $954M | $1.2B | $1.2B | $1.1B |
| Interest expense | $88M | $88M | $85M | $97M | $99M | $99M | $106M | $90M | $90M | $88M |
| Pre-tax income | $983M | $1.0B | $1.1B | $1.0B | $1.2B | $900M | $607M | $238M | $398M | $1.1B |
| Income tax | $335M | $330M | $231M | $204M | $246M | $181M | $136M | $77M | $106M | $254M |
| Net income | $648M | $701M | $823M | $820M | $939M | $710M | $462M | $149M | $280M | $810M |
| EPS (diluted) | $4.92 | $5.33 | $6.26 | $6.32 | $7.36 | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 |
| Diluted shares | 132M | 132M | 132M | 130M | 128M | 127M | 124M | 124M | 125M | 124M |
| Gross margin | 45.1% | 44.7% | 43.7% | 43.9% | 45.6% | 43.6% | 35.8% | 39.4% | 43.0% | 45.2% |
| Net margin | 11.2% | 11.7% | 13.4% | 13.2% | 14.0% | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% |
Balance sheet
Fiscal years, from Clorox's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $401M | $418M | $131M | $111M | $871M | $319M | $183M | $367M | $202M | $167M |
| Receivables | $569M | $565M | $600M | $631M | $648M | $604M | $681M | $688M | $695M | $821M |
| Inventory | $443M | $459M | $506M | $512M | $454M | $752M | $755M | $696M | $637M | $523M |
| Total current assets | $1.5B | $1.5B | $1.3B | $1.3B | $2.0B | $1.8B | $1.7B | $1.8B | $1.6B | $1.6B |
| Property, plant and equipment | $906M | $931M | $996M | $1.0B | $1.1B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Goodwill | $1.2B | $1.2B | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B | $1.3B | $1.2B | $1.2B |
| Total assets | $4.5B | $4.6B | $5.1B | $5.1B | $6.2B | $6.3B | $6.2B | $5.9B | $5.8B | $5.6B |
| Total current liabilities | $1.6B | $1.8B | $1.2B | $1.4B | $1.4B | $2.1B | $1.8B | $1.9B | $1.6B | $1.9B |
| Long-term debt | $1.8B | $1.4B | $2.3B | $2.3B | $2.8B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B |
| Total liabilities | $4.2B | $4.0B | $4.3B | $4.6B | $5.3B | $5.7B | $5.4B | $5.6B | $5.3B | $5.1B |
| Shareholders' equity | $297M | $542M | $726M | $559M | $908M | $411M | $556M | $220M | $328M | $321M |
| Net debt | $1.4B | $1.4B | $2.2B | $2.6B | $1.9B | $2.5B | $2.3B | $2.1B | $2.3B | $2.3B |
Cash flow
Fiscal years, from Clorox's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $778M | $868M | $976M | $992M | $1.5B | $1.3B | $786M | $1.2B | $695M | $981M |
| Capital spending | $172M | $231M | $194M | $206M | $254M | $331M | $251M | $228M | $212M | $220M |
| Free cash flow | $606M | $637M | $782M | $786M | $1.3B | $945M | $535M | $930M | $483M | $761M |
| Stock-based compensation | $45M | $51M | $53M | $43M | $50M | $50M | $52M | $73M | $74M | $81M |
| Dividends paid | $398M | $412M | $450M | $490M | $533M | $558M | $571M | $583M | $595M | $602M |
| Share buybacks (net) | -$254M | -$183M | -$271M | -$661M | -$248M | -$905M | -$25M | $0 | $0 | -$332M |
| Net borrowing | $126M | -$125M | $277M | $189M | $96M | $0 | -$83M | -$188M | -$45M | $0 |
| Free cash flow margin | 10.5% | 10.7% | 12.8% | 12.6% | 19.2% | 12.9% | 7.5% | 12.6% | 6.8% | 10.7% |
| Dividends per share | $3.02 | $3.13 | $3.42 | $3.78 | $4.17 | $4.38 | $4.61 | $4.69 | $4.77 | $4.84 |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CLX.
Open CLX in InvestinglyQuestions
What was Clorox's revenue in 2025?
$7.1B in fiscal 2025, from its 10-K filing.
How much free cash flow does Clorox generate?
$761M in fiscal 2025 (operating cash flow minus capital spending).
From Clorox's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.